Acadian Asset Management’s Regulus Therapeutics RGLS Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-466
| Closed | – | – | 1745 |
|
2023
Q4 | $0 | Hold |
466
| – | – | ﹤0.01% | 1798 |
|
2023
Q3 | $0 | Hold |
466
| – | – | ﹤0.01% | 1806 |
|
2023
Q2 | $0 | Hold |
466
| – | – | ﹤0.01% | 1883 |
|
2023
Q1 | $0 | Hold |
466
| – | – | ﹤0.01% | 1930 |
|
2022
Q4 | $0 | Sell |
466
-7,583
| -94% | – | ﹤0.01% | 1893 |
|
2022
Q3 | $13K | Hold |
8,049
| – | – | ﹤0.01% | 1627 |
|
2022
Q2 | $17K | Buy |
+8,049
| New | +$17K | ﹤0.01% | 1626 |
|
2021
Q4 | – | Sell |
-24,619
| Closed | -$170K | – | 1823 |
|
2021
Q3 | $170K | Sell |
24,619
-35,883
| -59% | -$248K | ﹤0.01% | 1337 |
|
2021
Q2 | $492K | Buy |
60,502
+13,934
| +30% | +$113K | ﹤0.01% | 1164 |
|
2021
Q1 | $726K | Buy |
+46,568
| New | +$726K | ﹤0.01% | 1061 |
|
2020
Q3 | – | Sell |
-1,768
| Closed | -$12K | – | 2323 |
|
2020
Q2 | $12K | Buy |
+1,768
| New | +$12K | ﹤0.01% | 2161 |
|